Evonik Industries has commenced construction on an €80 million biotechnology expansion at its Fermas site in Slovakia, targeting completion in early 2028 to boost pharmaceutical intermediate manufactu
Evonik Industries in Slovakia utilizes engineered microbes to ferment renewable raw materials into products like pharmaceutical ingredients and biopolymers. This investment demonstrates a viable pathw
Evonik Industries AG reported a 31% drop in Q2 net profit due to impairments, yet adjusted EBITDA beat estimates driven by higher volumes and prices. The company upgraded its 2026 outlook citing Middl
Evonik Industries will utilize Celtic Renewables' bio-based butanol, derived from local feedstocks like whiskey pot ale, to produce sustainable cosmetic emollients. This partnership aims to reduce Sco
Evonik Industries AG upgraded its 2026 adjusted EBITDA guidance to €2.0–2.2 billion following strong Q2 performance, exceeding prior forecasts of €1.7–2.0 billion.
Evonik Industries has agreed to sell selected pharmaceutical ingredient production assets at its Hanau site to contract manufacturer ProChem Group. The move aligns with Evonik's strategy to streamline
Evonik Industries announced an extension of its restructuring program, cutting 3,200 additional jobs by 2029 and discontinuing its unprofitable polyester business by 2027. The move aims to improve eff
Evonik Industries AG has partnered with the University of Guanajuato to develop sustainable, lower-toxicity chemical solutions for mining using its biosurfactant platform. The collaboration aims to re
Evonik partnered with MTCO to supply SEPURAN Green membranes for biogas purification in Malaysia. The polyimide technology converts biogas to LNG-quality biomethane with low energy consumption across
Evonik Industries AG signed an agreement to supply its Sepuran Green membrane technology to Malaysian bioenergy firm MTC Orec Sdn Bhd for biogas upgrading projects across Asia. The proprietary membran
Evonik Industries maintained its 2026 adjusted EBITDA guidance of €1.7–2.0 billion, noting no expected recovery in global chemical demand despite strong performance in China.
ChemBrief